(Q37118911)

18 August 2017

1 reference

title

A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding (English)

1 reference

18 August 2017

1 reference

1 reference

Ian S Fraser

1

1 reference

18 August 2017

Robert J Porte

series ordinal

2

1 reference

18 August 2017

Peter A Kouides

series ordinal

3

1 reference

18 August 2017

Andrea S Lukes

series ordinal

4

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

number of pages

8

1 reference

inferred from page(s)

published in

Drug Safety

1 reference

18 August 2017

volume

31

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

275-282

1 reference

Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review

18 August 2017

cites work

1 reference

12 December 2020

The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid

1 reference

12 December 2020

FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health

1 reference

12 December 2020

Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent.

1 reference

12 December 2020

A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding

1 reference

12 December 2020

The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding

1 reference

12 December 2020

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding.

1 reference

12 December 2020

Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives

1 reference

12 December 2020

High dose of tranexamic acid for treatment of severe menorrhagia in patients with von Willebrand disease

1 reference

12 December 2020

von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management

1 reference

12 December 2020

Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery

1 reference

12 December 2020

Gynaecological and obstetric management of women with inherited bleeding disorders

1 reference

12 December 2020

Treatment of menorrhagia with meclofenamate sodium.

1 reference

12 December 2020

Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia

1 reference

12 December 2020

Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators

1 reference

12 December 2020

Management of excessive menstrual bleeding in women with hemostatic disorders

1 reference

12 December 2020

Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

1 reference

12 December 2020

Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices

1 reference

12 December 2020

A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

1 reference

12 December 2020

Meclofenamate inhibits prostaglandin E binding and adenylyl cyclase activation in human myometrium

1 reference

12 December 2020

Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3

1 reference

12 December 2020

Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment cha

1 reference

12 December 2020

Effect of fenamates on prostaglandin E receptor binding

1 reference

12 December 2020

Danazol and internal carotid artery thrombosis

1 reference

12 December 2020

Successful direct thrombolysis in a patient with extensive dural sinus thrombosis induced by danazol

1 reference

12 December 2020

Tranexamic acid: a review of its use in the management of menorrhagia

1 reference

12 December 2020

Surgery versus medical therapy for heavy menstrual bleeding

1 reference

12 December 2020

The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders

1 reference

12 December 2020

Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time

1 reference

12 December 2020

Cyclical progestogens for heavy menstrual bleeding.

1 reference

12 December 2020

DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study.

1 reference

12 December 2020

Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia

1 reference

12 December 2020

Antifibrinolytics for heavy menstrual bleeding

1 reference

12 December 2020

Thromboembolic disease and present oral contraception

1 reference

12 December 2020

Modern management of menorrhagia

1 reference

12 December 2020

Menorrhagia, mechanisms and targeted therapies

1 reference

12 December 2020

A comparative review of the risks and benefits of hormone replacement therapy regimens

1 reference

12 December 2020

Treating Menorrhagia in Primary Care: An Overview of Drug Trials and a Survey of Prescribing Practice

1 reference

12 December 2020

Long-term use of the levonorgestrel-releasing intrauterine system

1 reference

12 December 2020

Progestogen-only contraception in women at high risk of venous thromboembolism

1 reference

12 December 2020

Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate

1 reference

12 December 2020

Danazol and limb-threatening arterial thrombosis: two case reports

1 reference

12 December 2020

Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study

1 reference

12 December 2020

No increased risk of venous thrombosis in women taking tranexamic acid

1 reference

12 December 2020

Benefits and risks of pharmacological agents used for the treatment of menorrhagia

1 reference

12 December 2020

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

1 reference

12 December 2020

Treatment of menorrhagia

1 reference

12 December 2020

Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia

1 reference

12 December 2020

Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview

1 reference

12 December 2020

Venous and arterial thrombosis during oral contraceptive use: risks and risk factors

1 reference

12 December 2020

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

1 reference

12 December 2020

A benefit-risk review of systemic haemostatic agents: part 1: in major surgery

1 reference

12 December 2020

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding

1 reference

12 December 2020

High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

1 reference

12 December 2020

Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss

1 reference

12 December 2020

Menorrhagia: an update

1 reference

12 December 2020

On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin

1 reference

12 December 2020

Oral contraceptives and the risk of venous thromboembolism

1 reference

12 December 2020

10.2165/00002018-200831040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1042748656

0 references

1 reference